Marcia Belvin Cytom X Therapeutics, Inc. (CTMX) insider trading activity

CTMX Quotes by TradingView

Marcia Belvin is SVP, Chief Scientific Officer of CytomX Therapeutics, Inc.. Currently has a direct ownership of 175,648 shares of CTMX, which is worth approximately $159,839. The most recent transaction as insider was on Aug 20, 2024, when has been sold 4,181 shares (Common Stock) at a price of $1.23 per share, resulting in proceeds of $5,142. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 176K
4.19% 3M change
18.72% 12M change
Total Value Held $159,839

MARCIA BELVIN Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 20 2024
SELL
Open market or private sale
$5,142 $1.23 p/Share
4,181 Reduced 2.32%
175,648 Common Stock
Aug 20 2024
BUY
Exercise of conversion of derivative security
-
11,250 Added 5.89%
179,829 Common Stock
Mar 19 2024
SELL
Open market or private sale
$26,741 $2.09 p/Share
12,795 Reduced 7.05%
168,579 Common Stock
Jan 18 2024
BUY
Grant, award, or other acquisition
-
26,250 Added 12.64%
181,374 Common Stock
Dec 20 2023
SELL
Open market or private sale
$5,626 $1.38 p/Share
4,077 Reduced 2.56%
155,124 Common Stock
Dec 17 2023
BUY
Exercise of conversion of derivative security
-
11,250 Added 6.6%
159,201 Common Stock
Sep 22 2023
SELL
Open market or private sale
$5,354 $1.3 p/Share
4,119 Reduced 2.71%
147,951 Common Stock
Sep 20 2023
BUY
Grant, award, or other acquisition
-
11,250 Added 6.89%
152,070 Common Stock
Mar 22 2023
BUY
Grant, award, or other acquisition
-
60,000 Added 29.88%
140,820 Common Stock
MB

Marcia Belvin

SVP, Chief Scientific Officer
South San Francisco, CA

Track Institutional and Insider Activities on CTMX

Follow CytomX Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CTMX shares.

Notify only if

Insider Trading

Get notified when an Cytom X Therapeutics, Inc. insider buys or sells CTMX shares.

Notify only if

News

Receive news related to CytomX Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on CTMX